share_log

EF Hutton Assumes Ocean Biomedical at Buy, Announces Price Target of $17

Benzinga ·  May 25, 2023 07:16

EF Hutton analyst Tony Butler assumes Ocean Biomedical (NASDAQ:OCEA) with a Buy rating and announces Price Target of $17.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment